Unsupervised clustering approach to assess heterogeneity of treatment effects across patient phenotypes in randomized clinical trials.

Abstract excerpt

BACKGROUND: Primary results from randomized clinical trials (RCT) only inform on the average treatment effect in the studied population, and it is critical to understand how treatment effect varies across subpopulations. In this paper we describe a clustering-based approach for the assessment of Heterogeneity of Treatment Effect (HTE) over patient phenotypes, which maintains the unsupervised nature of classical...

Topics

Join the communities discussing this publication.

• Anticoagulants
• Atrial Fibrillation
• Cluster Analysis
• Pyridines
• Randomized Controlled Trials as Topic